Chronic GvHD
The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD following Hematopoietic Stem Cell Transplantation
6
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.
42
Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.
26
Hematopoietic stem cell transplantation
13
PubMedCentral-PMC4715914.pdf
20
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease
16
Prognostic Implications of the NIH Consensus Criteria in Children with Chronic Graft versus Host Disease
8
Ibrutinib treatment ameliorates murine chronic graft versus host disease
11
Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
5
Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft versus host disease
9
C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans
16
A fast and fatal course of bronchiectasis: an unusual rare expression of chronic graft versus host disease. A case report
6
Ocular Graft versus Host Disease: A Review of Clinical Manifestations, Diagnostic Approaches and Treatment
14
Enhanced allostimulatory activity of host antigen presenting cells in old mice intensifies acute graft versus host disease
9
Value of Interleukin-7 and Interleukin-15 as Predictors of Graft Versus Host Disease in Recipients of Allogeneic Bone Marrow Transplantation
19
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
8
Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial
7
Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation.
26
Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
11
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.
21